Neoprol Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Seed
- Investors
-
2
Neoprol General Information
Description
Developer of a synthetic proprietary formulation designed to focus on the preparation of anesthesia drugs. The company's medical formulations offer the development of propofol products used for intravenous induction and maintenance of anesthesia, enabling patients to avoid any side effects of anesthesia.
Contact Information
Corporate Office
- Givat Ram
- Jerusalem
- Israel
Corporate Office
- Givat Ram
- Jerusalem
- Israel
Neoprol Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 01-Mar-2019 | Completed | Pre-Clinical Trials | |||
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
Neoprol Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Integra Holdings | Venture Capital | Minority | ||
| Yissum | Accelerator/Incubator |
Neoprol FAQs
-
When was Neoprol founded?
Neoprol was founded in 2014.
-
Where is Neoprol headquartered?
Neoprol is headquartered in Jerusalem, Israel.
-
What industry is Neoprol in?
Neoprol’s primary industry is Drug Discovery.
-
Is Neoprol a private or public company?
Neoprol is a Private company.
-
What is Neoprol’s current revenue?
The current revenue for Neoprol is .
-
Who are Neoprol’s investors?
Integra Holdings and Yissum have invested in Neoprol.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process